Increased number of circulating endothelial cells (CECs) in patients with psoriasis - Preliminary report

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 1, 2014, Pages 116-119

  Batycka Baran, A ^a   Paprocka, M ^b   Krawczenko, A ^b   Dus D ^b   Szepietowski, J C ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CD146 ANTIGEN; CD45 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELECTIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BODY MASS; CIRCULATING ENDOTHELIAL CELL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

ADULT; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS;

EID: 84890558669     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04671.x     Document Type: Article

References (20)

1. Prodanovich S, Kirsner RS, Kravetz JD, et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009; 20: 303-307.
2. Boehncke WH, Boehncke S, Tobin AM, Kirby B,. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011; 20: 303-307.
3. Balci DD, Balci A, Karazincir S, et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 1-6.
4. Yiu KH, Yeung CK, Chan HT, et al. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol 2011; 164: 514-520.
5. Endemann DH, Schiffrin EL, et al. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-1992.
6. Kasprzak JD, Kłosińska M, Drozdz J,. Clinical aspects of assessment of endothelial function. Pharmacol Rep 2006; 58: 33-40.
7. Bijl M,. Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases. Neth J Med 2003; 61: 273-277.
8. Szmitko PE, Wang CH, Weisel RD, et al. New markers of inflammation and endothelial cell activation: part I. Circulation 2003; 108: 1917-1923.
9. Blann AD, Woywodt A, Bertolini F, et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005; 93: 228-235.
10. Shantsila E, Blann AD, Lip GY,. Circulating endothelial cells: from bench to clinical practice. J Thromb Haemost 2008; 6: 865-868.
11. Erdbruegger U, Haubitz M, Woywodt A,. Circulating endothelial cells: a novel marker of endothelial damage. Clin Chim Acta 2006; 373: 17-26.
12. Davidovici BB, Sattar N, Prinz JC, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-1796.
13. Hansson GK, Hermansson A,. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-212.
14. Makin AJ, Blann AD, Chung NA, et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Eur Heart J. 2004; 25: 371-376.
15. Arenberger P, Buchtová L, Hladovec J,. Increase of endothelaemia in psoriasis. Acta Derm Venereol 1993; 73: 35-36.
16. Sochorova R, Svecova D, Sinka L, Rybarova L,. Increased endothelemia as an indirect marker of changes in the blood vessel endothelium in psoriasis. J Eur Acad Dermatol Venereol 2004; 18: 556-559.
17. Borská L, Fiala Z, Krejsek J, et al. Selected immunological changes in patients with Goeckerman's therapy TNF-alpha, sE-selectin, sP-selectin, sICAM-1 and IL-8. Physiol Res 2006; 55: 699-706.
18. Szepietowski J, Wasik F, Bielicka E, et al. Soluble E-selectin serum levels correlate with disease activity in psoriatic patients. Clin Exp Dermatol 1999; 24: 33-36.
19. Blann AD, McCollum CN,. von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg 1994; 8: 10-15.
20. Duţu A, Rus V, Boloşiu HD, et al. von Willebrand factor in the plasma of patients with rheumatic diseases. Med Interne 1989; 27: 273-278.